Antioxidant status in experimental type 2 diabetes mellitus: Effects of glibenclamide and glipizide on various rat tissues

Experimental and Toxicologic Pathology

Volumn 51, Issue 4-5, 1999, Pages 436-441

  Tüzün, Sevgi ^a   Girgin, Ferhan K ^a   Sözmen, Eser Y ^a   Menteş, Gülriz ^a   Ersöz, Biltan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Antioxidant status; Diabetes mellitus; Glibenclamide; Glipizide

Indexed keywords

CATALASE; GLIBENCLAMIDE; GLIPIZIDE; MALONALDEHYDE; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERGLYCEMIA; LIPID PEROXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

ANIMALIA;

EID: 17144450247     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0940-2993(99)80036-0     Document Type: Conference Paper

References (26)

1. PORTHA B, BLONDEL O, SERRADAS P, et al.: The rat models of non-insulin dependent diabetes induced by neonatal STZ. Diabete Metab 1989; 15: 61-75.
2. KUMAR SA, SRIVASTAVA P, KALE RK, BAQUER NZ: Impaired antioxidant status in diabetic rat liver, effect of vanadate. Biochemical Pharmacology 1993; 45: 539-542.
3. CARONE D, LOVERRO G, GRECO P, et al.: Lipid peroxidation products and antioxidant enzymes in red blood cells during normal and diabetic pregnancy. European Journal of Obstetrics and Gynecology and Reproductive Biology 1993; 51: 103-109.
4. MAXWELL SRJ, THOMASON H, SANDLER D, et al.: Poor glycemic control is associated with reduced serum free radical scavenging activity in type 2 diabetes. Ann Clin Biochem 1997; 34: 638-644.
5. SALEH A, WOHAEIB and DAVID V GODIN: Alterations in free radical tissue-defense mechanisms in STZ-induced diabetes in rat. Diabetes 1987; 36: 1014-1018.
6. ALTAN N, ONGUN CÖ, HASANOǦLU E, et al.: Effect of sulfonylurea glyburide on superoxide dismutase activity in alloxan induced diabetic rat hepatocytes. Diabetes research and clinical practice 1994; 22: 95-98.
7. AEBI H: Catalase in vitro. Methods in Enzymology 1984; 105: 121-126.
8. TANYALÇIN T, SÖZMEN EY, TAŞKIRAN D, et al.: The endogenous scavengers in cerulein induced acute pan-creatitis. Eur J Clin Chem Clin Biochem 1995; 33: 195-199.
9. RUNGBY J, FLYVBJERG A, ANDERSEN HB, NYBORG K: Lipid peroxidation in early experimental diabetes in rats: effects of diabetes and insulin. Acta Endocrinologica 1992; 26: 378-380.
10. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ: Protein measurement with folin phenol reagent. J Biol Chem 1951; 193: 265-275.
11. ASAYAMA K, ENGLISH D, SLONIM AE, BURR IM: Chemiluminescence as an index of drug-induced free radical production in pancreatic islets. Diabetes 1984; 33: 160-163.
12. LOVEN D, SCHEDL H, WILSON H, et al.: Effect of insulin and oral glutathione on glutathione levels and SOD activities in organs of rats with STZ-induced diabetes. Diabetes 1986; 35: 503-507.
13. AKANJI AO, NG L, HUMPHREYS S: Plasma acetate levels in response to intravenous fat or glucose/insulin infusions in diabetic and non-diabetic subjects. Clin Chim Acta 1988; 178: 85-94.
14. TAYLOR R, AGIUS L: The biochemistry of diabetes. Biochem J 1988; 250: 625-640.
15. SAIN SK, PALMER M: The effect of oxygen radicals metabolites and vit E on glycosylation of proteins. Free Radical Biology and Medicine 1997; 22: 593-596.
16. KOLTERMAN OG, GRAY RS, SHAPIRO G, et al.: The acute and chronic effects of sulfonylurea therapy in type 2 diabetic subjects. Diabetes 1984; 33: 346-354.
17. KUMAR JS, MENON VP: Peroxidative changes in experimental diabetes mellitus. Indian J Med Res(B) 1992; 96: 176-181.
18. ALTOMARE E, VENDEMIALE G, CHICCO D: Increased lipid peroxidation in type 2 poorly controlled diabetic patients. Diabete Metab 1992; 18: 264-271.
19. SALEH A, WOHAEIB and DAVID V GODIN: Starvation related alterations in free radical tissue defense mechanisms in rats. Diabetes 1987; 36: 169-172.
20. KUMAR JS, MENON VP: Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain. Metabolism 1993; 42: 1435-1439.
21. MANS AM, DEJOSEPH MR, DAVIS DW, HAWKINS RA: Brain energy metabolism in STZ diabetes. Biochem J 1988; 249: 57-62.
22. MCDERMOTT BM, FLATT PR, STRAIN JJ: Effects of copper deficiency and experimental diabetes on tissue antioxidant enzyme levels in rats. Ann Nutr Metab 1994; 38: 263-269.
23. HARROWER ADB: Comparison of efficacy, secondary failure rate, and complications of sulfonylureas. J Diab Comp 1994; 8: 201-203.
24. MARCHETTI P, GIANNARELLI R, CARLO A, NAVALESI R: Pharmacokinetic optimisation of oral hypoglycaemic therapy. Clin Pharmacokinet 1991; 21: 308-317.
25. SCOTT NA, JENNINGS PE, BROWN J, BELCH JF: Gliclazide: a general free radical scavenger. European Journal of Pharmacology-Molecular Pharmacology Section 1991; 208: 175-177.
26. BONORA E, PISANI F, MICCIOLO R, et al: Effect of glipizide on insulin secretion and insulin metabolism in obese type 2 diabetic patients. Diabetes Care 1987; 10: 687-691.